
A diverse array of zzso B zzso viruses zzso in Africa and dominates the global zzso It is important to understand how drug resistance zzso in non-B zzso may develop differently from the patterns described in zzso zzso zzso reverse zzso and zzso sequences from 338 patients with treatment failure to zzso ART regimens were zzso zzso zzso zzso was used to examine the effect of zzso on each zzso controlling for regimen, time on therapy, and total zzso The distribution of zzso zzso included zzso zzso G zzso zzso zzso A zzso and other zzso or zzso sequences zzso The most common zzso zzso were zzso zzso and zzso analog zzso zzso The most common zzso zzso were zzso zzso zzso zzso zzso zzso and zzso zzso zzso analysis showed that zzso was less likely to have the zzso zzso compared to other zzso zzso odds ratio zzso zzso zzso A patients showed a zzso increased risk zzso zzso for the zzso zzso Among zzso zzso zzso G patients had an increased risk for zzso zzso zzso and zzso zzso zzso whereas zzso zzso patients had an increased risk for zzso zzso zzso and a decreased risk for zzso zzso zzso Five zzso zzso were found to vary significantly between different non-B West African zzso Further study to understand the clinical impact of zzso diversity on drug resistance will be critically important to the continued success of ART zzso in zzso zzso 

